Bactiguard Holding
68.4 SEK -0.58%Be the first to follow this company
Bactiguard is a global MedTech company that prevent infections related to medical devices. The technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation. Bactiguard operates through license partnerships with MedTech companies that apply the technology to their medical devices. The company also has a portfolio of wound management products. Bactiguard has its headquarters in Stockholm.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
BACTI B
Daily low / high price
66.6 / 71
SEK
Market cap
2.4B SEK
Turnover
473.8K SEK
Volume
6.9K
Latest videos
Financial calendar
Interim report
16.07.2024
Interim report
24.10.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
TomBact AB | 18.4 % | 34.4 % |
GIDL Invest AB | 17.6 % | 34.0 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
![Bactiguard, Audiocast with teleconference, Q2'24](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/9bf8e469-7f16-4a09-85ef-dfb0d9c9f195.png)
Bactiguard, Audiocast with teleconference, Q2'24
Bactiguard Holding AB (publ): Bactiguard Holding AB's interim report second quarter 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Bactiguard Holding AB (publ): Invitation to presentation of Bactiguard's interim report for the second quarter 2024
Carnegie Commissioned Research: Bactiguard: Sales growth returns – Q2 preview
Bactiguard Holding AB (publ): Bulletin from Bactiguard Holding AB's (publ) Annual General Meeting
Carnegie Commissioned Research: Bactiguard: Sales need to pick up for the stock to move
![Bactiguard, Audiocast with teleconference, Q1, 2024](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/2f779307-e5e8-4706-8b37-656078037ee8.png)
Bactiguard, Audiocast with teleconference, Q1, 2024
Bactiguard Holding AB (publ): Bactiguard Holding AB's interim report first quarter 2024
Carnegie Commissioned Research: Bactiguard: Still too early for sales growth to have returned – Q1 preview
Bactiguard Holding AB (publ): Invitation to presentation of Bactiguard's interim report for the first quarter 2024
Bactiguard Holding AB (publ): Christine Lind assumes role as CEO of Bactiguard Holding AB as of today
Bactiguard Holding AB (publ): Notice to attend the Annual General Meeting of Bactiguard Holding AB
Bactiguard Holding AB (publ): Christian Kinch assumes role as senior advisor to Bactiguard and declines re-election to the board
Bactiguard Holding AB (publ): Bactiguard Holding AB's Annual and Sustainability Report 2023
Carnegie Commissioned Research: Bactiguard
![Bactiguard, Audiocast with teleconference, Q4, 2023](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/1d1d5b77-5cef-49aa-a958-fa6df1ca7a7c.png)